$6.11
-0.57-8.53%
À la fermeture: -
$6.12
0.010000.16%
Après les heures de négociation: 7:59 PM EDT
Comments
Loading...
Recursion Pharmaceuticals Rapport sur les positions courtes
RXRXNASDAQ
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Recursion Pharmaceuticals Inc (NASDAQ:RXRX) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 132.04M à 133.41M. Cela représente 32.79% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Recursion Pharmaceuticals Corp (XNAS:RXRX) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 35.93M actions échangées par jour, il faudrait 3.71 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
133.41M
Intérêt à court terme %
32.8%
Jours de couverture
3.71
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
RXRX | Recursion Pharmaceuticals, Inc | 09/30/2025 | 10/09/2025 | 32.79% | 406,854,783 | 133,407,394 | 35,928,102 | 3.71 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/15/2025 | 09/24/2025 | 32.45% | 406,854,783 | 132,044,177 | 16,730,338 | 7.89 | |
RXRX | Recursion Pharmaceuticals, Inc | 08/29/2025 | 09/10/2025 | 30.50% | 406,854,783 | 124,079,106 | 16,288,078 | 7.62 | |
RXRX | Recursion Pharmaceuticals, Inc | 08/15/2025 | 08/26/2025 | 30.26% | 403,883,402 | 122,223,405 | 18,598,548 | 6.57 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/31/2025 | 08/11/2025 | 29.10% | 403,883,402 | 117,535,748 | 33,007,194 | 3.56 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/15/2025 | 07/24/2025 | 28.60% | 403,883,402 | 115,527,481 | 30,617,579 | 3.77 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/30/2025 | 07/10/2025 | 29.07% | 403,883,402 | 117,408,745 | 27,422,295 | 4.28 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/13/2025 | 06/25/2025 | 31.87% | 376,801,373 | 120,075,634 | 36,749,679 | 3.27 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/30/2025 | 06/10/2025 | 28.94% | 376,801,373 | 109,034,492 | 19,542,619 | 5.58 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/15/2025 | 05/27/2025 | 27.66% | 376,801,373 | 104,219,046 | 22,023,595 | 4.73 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/30/2025 | 05/09/2025 | 24.71% | 376,801,373 | 93,117,686 | 14,415,360 | 6.46 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/15/2025 | 04/25/2025 | 25.57% | 369,684,676 | 94,515,655 | 30,201,892 | 3.13 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/31/2025 | 04/09/2025 | 23.94% | 369,684,676 | 88,501,554 | 15,553,625 | 5.69 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/14/2025 | 03/25/2025 | 23.38% | 369,684,676 | 86,416,564 | 20,466,609 | 4.22 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/28/2025 | 03/11/2025 | 21.83% | 369,684,676 | 80,716,710 | 37,222,808 | 2.17 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/14/2025 | 02/26/2025 | 21.06% | 358,336,087 | 75,450,107 | 33,427,821 | 2.26 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/31/2025 | 02/11/2025 | 17.79% | 358,336,087 | 63,748,978 | 17,727,159 | 3.6 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/15/2025 | 01/27/2025 | 18.94% | 358,336,087 | 67,857,806 | 15,986,169 | 4.24 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/31/2024 | 01/10/2025 | 20.68% | 356,513,648 | 73,735,739 | 16,275,526 | 4.53 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/13/2024 | 12/24/2024 | 18.82% | 356,513,648 | 67,097,533 | 17,100,772 | 3.92 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/29/2024 | 12/10/2024 | 19.03% | 356,513,648 | 67,845,763 | 12,760,225 | 5.32 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/15/2024 | 11/26/2024 | 18.12% | 356,353,259 | 64,573,303 | 6,991,077 | 9.24 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/31/2024 | 11/11/2024 | 24.56% | 254,214,840 | 62,427,631 | 3,799,526 | 16.43 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/15/2024 | 10/24/2024 | 22.97% | 258,803,877 | 59,436,441 | 4,461,852 | 13.32 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/30/2024 | 10/09/2024 | 30.91% | 202,439,295 | 62,578,756 | 5,425,024 | 11.54 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/13/2024 | 09/24/2024 | 29.22% | 202,439,295 | 59,162,424 | 4,852,523 | 12.19 | |
RXRX | Recursion Pharmaceuticals, Inc | 08/30/2024 | 09/11/2024 | 27.68% | 202,439,295 | 56,030,343 | 4,357,903 | 12.86 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/31/2024 | 08/09/2024 | 24.88% | 202,439,295 | 50,366,647 | 3,844,470 | 13.1 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/15/2024 | 07/24/2024 | 26.18% | 188,412,721 | 49,327,170 | 5,762,041 | 8.56 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/28/2024 | 07/10/2024 | 23.84% | 188,412,721 | 44,919,972 | 9,626,203 | 4.67 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/14/2024 | 06/26/2024 | 28.50% | 157,643,491 | 44,931,836 | 3,773,645 | 11.91 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/31/2024 | 06/11/2024 | 27.68% | 157,643,491 | 43,637,834 | 4,499,180 | 9.7 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/15/2024 | 05/24/2024 | 26.88% | 157,643,491 | 42,368,012 | 5,893,334 | 7.19 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/30/2024 | 05/09/2024 | 25.69% | 157,643,491 | 40,497,913 | 4,247,037 | 9.54 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/15/2024 | 04/24/2024 | 24.58% | 157,477,026 | 38,704,268 | 4,392,347 | 8.81 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/28/2024 | 04/09/2024 | 25.44% | 156,275,453 | 39,761,938 | 5,885,026 | 6.76 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/15/2024 | 03/26/2024 | 27.85% | 156,275,453 | 43,520,191 | 7,080,455 | 6.15 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/29/2024 | 03/11/2024 | 27.40% | 156,275,453 | 42,815,751 | 11,571,921 | 3.7 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/15/2024 | 02/27/2024 | 27.83% | 137,415,977 | 38,240,528 | 5,530,719 | 6.91 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/31/2024 | 02/09/2024 | 27.85% | 137,415,977 | 38,272,534 | 4,993,651 | 7.66 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/12/2024 | 01/24/2024 | 27.72% | 137,415,977 | 38,088,079 | 8,653,427 | 4.4 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/29/2023 | 01/10/2024 | 26.95% | 137,415,977 | 37,036,264 | 4,553,307 | 8.13 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/15/2023 | 12/27/2023 | 26.94% | 137,415,977 | 37,016,053 | 5,263,124 | 7.03 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/30/2023 | 12/11/2023 | 26.14% | 137,415,977 | 35,921,010 | 4,598,000 | 7.81 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/15/2023 | 11/27/2023 | 25.83% | 137,415,977 | 35,495,991 | 5,290,105 | 6.71 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/31/2023 | 11/09/2023 | 24.05% | 137,415,977 | 33,049,509 | 2,410,830 | 13.71 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/13/2023 | 10/24/2023 | 23.92% | 133,170,384 | 31,848,663 | 2,683,907 | 11.87 |
À la recherche des actions les plus vendues à découvert?